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Abstract
Background: Close, continuous and efficient collaboration between different professions and sectors of care is
necessary to provide patient-centered care for individuals with mental disorders. The lack of structured collaboration
between in- and outpatient care constitutes a limitation of the German health care system. Since 2012, a new law in
Germany (§64b Social code book (SGB) V) has enabled the establishment of cross-sectoral and patient-centered
treatment models in psychiatry. Such model projects follow a capitation budget, i.e. a total per patient budget of
inpatient and outpatient care in psychiatric clinics. Providers are able to choose the treatment form and adapt the
treatment to the needs of the patients. The present study (EVA64) will investigate the effectiveness, costs and efficiency
of almost all model projects established in Germany between 2013 and 2016.
Methods/design: A health insurance data-based controlled cohort study is used. Data from up to 89 statutory health
insurance (SHI) funds, i.e. 79% of all SHI funds in Germany (May 2017), on inpatient and outpatient care, pharmaceutical
and non-pharmaceutical treatments and sick leave for a period of 7 years will be analyzed. All patients insured by any
of the participating SHI funds and treated in one of the model hospitals for any of 16 pre-defined mental disorders will
be compared with patients in routine care. Sick leave (primary outcome), utilization of inpatient care (primary outcome)
, utilization of outpatient care, continuity of contacts in (psychiatric) care, physician and hospital hopping, re-admission
rate, comorbidity, mortality, disease progression, and guideline adherence will be analyzed. Cost and effectivity of
model and routine care will be estimated using cost-effectiveness analyses. Up to 10 control hospitals for each of the 18
model hospitals will be selected according to a pre-defined algorithm.
Discussion: The evaluation of complex interventions is an important main task of health services research and constitutes
the basis of evidence-guided advancement in health care. The study will yield important new evidence to guide the
future provision of routine care for mentally ill patients in Germany and possibly beyond.
Trial registration: This study was registered in the database “Health Services Research Germany” (trial number:
VVfD_EVA64_15_003713).
Keywords: Claims data, Psychiatric health care, Effectiveness and cost-effectiveness, Routine data, Statutory health
insurance, Inpatient and outpatient treatment, Setting approach, Health care system, Health services research
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Background
Mental disorders are complex and characterized by a long
duration until adequate diagnosis and treatment [1]. The
German Bundestag Study Commission on Psychiatry urged,
already in the 1970ies, for new models of care aiming at,
e.g., preference of outpatient over inpatient care (where
possible), the equality of mentally and somatically ill
patients and a regionalized health care [2]. A continuous,
close and efficient collaboration between different profes-
sions and sectors of care is necessary to provide patient-
centered care for patients with mental health problems [3,
4]. Insufficient interfaces between different health care sec-
tors are a fundamental problem in the current German
healthcare system, but particularly of concern in psychiatric
care [5]. Insufficient trans-sectoral interfaces concern the
transition from inpatient to outpatient care, the joint care
of patients involving several specialists and the transition
from rehabilitation to the first labor market [6, 7].
In addition, the financing of the German psychiatric
health care system is currently fragmented constituting
another barrier towards efficient collaboration across sec-
tors [8]. The current remuneration of care for mentally ill
patients has been suspected to lead to misdirected incen-
tives for inappropriate or inappropriately long inpatient
care [9] and more resource intensive treatment [10].
Inadequate information about available treatment pro-
grams, inadequate collaboration between sectors and
health care professions, misleading communication and
long waiting periods lead to difficulties in care and,
therefore, often to deterioration of the individual well-
being of those affected [4, 11, 12]. 75% of most mental
disorders manifest between age seven and 24 [1]; and
those disorders often persist over many years [13].
Therefore, a sound collaboration between care of chil-
dren and adolescents with adult care including a joint
care during transition into adulthood is vital, though
often not processed adequately in Germany.
About 87% of the German population (i.e. 71.9 million
people) is insured through statutory health insurance
(SHI) funds, and about 10% is covered by private health
insurance (PHI) funds [14–16]. SHI funds cover all em-
ployees with a gross income of up to a contribution as-
sessment ceiling (EUR 3825 per month or EUR 45,900 per
year as of 2012) and their non-working family members
(spouses and children) [14]. Individuals whose income is
above the contribution assessment ceiling can voluntarily
enroll in SHIs or switch to PHIs [14].
Several health care models that aim to change the incen-
tives in the current system, to improve medical care of
mentally ill patients and to arrive at a more rational use of
resources have been investigated [8, 17]. Since 2012, a
new law (§64b Social Code Book (SGB) V) has enabled
the establishment of models that focus on cross-sectoral
and patient-centered health care for mentally ill patients
in Germany. For this, SHI funds can contract with hospi-
tals and jointly establish the new structure according to
§64b SGB V (model contracts). The common characteris-
tic of all model contracts / model projects is a total budget
of inpatient care and hospital-based psychiatric outpatient
clinic (capitation principle).
According to the capitation principle, a lump sum is al-
located to the model hospital each year of contract. If the
patient has to be treated more than once in a year, the pa-
tient is only counted once but the treatment has to be paid
by the model hospital [18]. The model hospital has to
cover all of its expenses with the contracted lump sum,
but is free to offer all forms of treatments, including in-
patient, outpatient or home treatment. The model hospital
can construct models of care that suit the region and meet
the community members’ needs [19]. International and
national results indicate that systems under capitation
principle can be as effective as routine care [20], more ef-
fective in the short-term [21, 22] or even worse compared
to routine care [23]. Some projects that follow the capita-
tion principle in psychiatric care have been established in
Germany (most on the basis of integrated care using
§140a SGB V); however, basic information about construct
and results of the projects need to be evaluated on a com-
mon basis [24]. For a shift from model projects to routine
psychiatric care in Germany, a common structure, such as
§64b SGB V, and a scientific common evaluation, such as
the here described study, are necessary [3].
The aims of the projects according to §64b SGB V include
the establishment of transparent processes and a reduction
of disincentives for a cost-effective use of available resources.
In specific terms, the aims of the model projects are:
(A)The implementation and advancement of an
optimized patient care through cross-sectoral
treatment,
(B) The enforcement of outpatient treatment options
with consecutively improved adaptation of duration
and intensity of treatment to the individual
treatment needs of mentally ill patients,
(C) A continuous treatment and stabilization of patients
under consideration of their social and occupational
environment,
(D)The improvement of acceptance of patient-oriented
psychiatric, psychotherapeutic and socio-
therapeutic interventions,
(E) The establishment of transparency,
(F) A more cost-effective use of available resources in
the health care of patients with mental disorders.
The supplementary law (§65 SGB V) further requires
evaluation of all of those models.
This manuscript describes the study design of the nation-
wide evaluation of model projects according to §64b SGB
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V in Germany using data from statutory health insurance
(SHI) funds (EVA64). The scientific use of claims data from
SHI funds for the evaluation of new health care concepts
has been established during the last years [25] including
analysis and reporting standards [26, 27].
Methods/design
Study population / inclusion criteria model hospitals
A health insurance data-based controlled cohort study
is conducted. All patients insured by any of the 89 par-
ticipating SHI funds, i.e. 79% of all SHI funds in
Germany (dated: May 2017 [28]), and treated in one of
the model hospitals due to any of the 16 pre-defined
mental disorders (Table 1) within the first 4 years after
initiation of a model contract and with a minimum
follow-up time of 1 year will be included. All 16 mental
disorders represent about 80–85% of all psychiatric
cases treated in hospitals [29]. A patient will only be
included in the analysis if his or her SHI fund has a
model contract with the model hospital and takes part
in the evaluation. Further, patients of comparable
control hospitals will be included as control patients
(more information on the selection of control hospitals
below). Anonymous patient data from the SHI funds
will be extracted. Due to the assessment of anonymous
data, it is not necessary to explicitly inform about the
study and informed consent is not obtained. All partici-
pating SHI funds had examined the accordance with
the data protection law.
Matching
Two stages of matching will be conducted. First, control
hospitals were allocated to each model hospital. Second,
patients will be matched between model and control
hospitals.
Control hospitals
The selection of comparable control hospitals was based on
a pre-defined algorithm using data from structured quality
reports according to §136b SGB V and matched data from
the Federal Institute for Research on Building, Urban Af-
fairs and Spatial Development (BBSR) [30], which included
sociodemographic and socioeconomic data on the level of
administrative districts (LANDKREISE). Since 2005, all
hospitals in Germany are obliged to publish selected struc-
tural data of their hospital in structured quality reports.
These data are collected in a database and available for re-
search and the public [31]. A priori defined knock-out cri-
teria (e.g. same region, institutionalized structures
(specialist departments and psychiatric outpatients depart-
ment (PIA))), criteria based on patients (i.e. number of
cases per diagnosis) (weighting 50%), structural features of
hospitals (e.g. number of beds or number of personnel)
(25%) and regional factors (e.g. unemployment rate, house-
hold income) (25%) were used to identify structurally com-
parable control hospitals for each model hospital. Further
details on the selection of the control hospitals based on
routine data can be found elsewhere [32]. Up to 10 control
hospitals for each model hospital were selected (with a
minimum of eight clinics for departments of general psych-
iatry and a minimum of three clinics for departments of
child and adolescence psychiatry).
To reach higher comparability between model and
control hospitals, only the first five of the 10 identified
control hospitals will be selected for analysis. If the five
best matched control hospitals do not provide at least
threefold the number of patients compared to the model
hospital, the next best fitting control hospitals will be
also selected step by step until the total number of pa-
tients from control hospitals is at least threefold as high
as the number of patients in the corresponding model
hospital. The remaining control hospitals might be se-
lected later in the study if, for example, chosen control
hospitals merge, close or turn into model hospitals.
Patient matching
Second, patients will be matched exactly according to
year of study inclusion, hospital-known vs. hospital-new
patient (hospital-new = no contact to psychiatric ward
or PIA in the corresponding model or control hospital
in the 2 years prior to study inclusion), diagnoses of
mental disorders at study inclusion and with propensity
score matching (nearest neighbor, caliper = 0.25 standard
deviation, without replacement) according to age and
Table 1 Inclusion criteria, diagnoses, International Classification
of Disease, 10th revision (ICD-10)
ICD-10 Diagnosis
F00 Dementia
F01 Vascular dementia
F02 Dementia in other diseases classified elsewhere
F03 Unspecified dementia
F07 Personality and behavioral disorders due to brain disease,
damage and dysfunction
F10 Mental and behavioral disorders due to use of alcohol
F20-F29 Schizophrenia, schizotypal and delusional disorders
F30-F39 Mood (affective) disorders
F43 Reaction to severe stress, and adjustment disorders
F45 Somatoform disorders
F40-F48 Neurotic, stress-related and somatoform disorders
F50 Eating disorders
F60.31 Specific personality disorders of type borderline
F70-F79 Mental retardation
F84 Pervasive developmental disorders
F90-F98 Behavioral and emotional disorders with onset occurring in
childhood and adolescence
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sex at study inclusion and health care utilization before
study inclusion. Each patient from model hospitals will
be paired with one best matched patient from a control
hospital, considering the match of the hospital and the
match of the patient characteristics.
Length of observation period
All patients who entered a model or control hospital
within the first 4 years after start of a model contract
will be included in the analysis and followed until the
end of year five since model establishment. In addition,
to estimate the effect of health care utilization before
model start, data of 2 years before study entrance will
also be analyzed (pre-time) (Fig. 1).
Outcome parameters
To operationalize the aims of the model projects, the
following outcome parameters will be analyzed (Fig. 2):
Primary outcome parameters
– frequency and duration of inpatient care, i.e.
percentage of patients with inpatient care and length
of hospital stay within 12 months after study
inclusion,
– sick leave, i.e. percentage of patients with at least
one sick leave episode, long-term sick leave (>
42 days in sick leave [33]) and number of days in
sick leave within 12 months after study inclusion.
Secondary outcome parameters
– frequency and intensity of outpatient care, i.e.
number of outpatient contacts in the psychiatric
health care system within 12 months after study
inclusion,
– cross-sectoral continuity, i.e. percentage of patients
having maximum 7, 30 or 90 days without
outpatient contact to the psychiatric health care
system after discharge from hospital within
12 months after study inclusion,
– discontinuation of contacts in psychiatric care, i.e.
percentage of patients with severe mental disorder
[34] without contact to the psychiatric health care
system for more than 3 or 6 months after study
inclusion [35],
– physician and hospital hopping, i.e. percentage of
patients with more than two different health service
providers within the same specialist department
(inpatient) or the same group of specialist physician
(outpatient) within 12 months after study inclusion,
– re-admission rate, i.e. percentage of patients with
any psychiatric diagnosis in two hospital stays within
12 months after discharge from hospital [36, 37],
– comorbidity, i.e. number of comorbidities based on
Elixhauser Score (ICD-10) without weighting [38],
– mortality, i.e. percentage of patients who die within
12 and 36 months after study inclusion,
– disease progression, i.e. percentage of patients who
either go on from a mild/moderate depressive
episode to a severe depressive episode, or from any
depressive episode to a recurrent depressive disorder
or who develop any addiction disorder within
12 months after study inclusion,
– guideline adherence, i.e. based on selected quality
indicators for alcohol dependency, dementia,
depression and schizophrenia which can be
estimated using SHI data [39].
The outcome parameters cross-sectoral continuity,
discontinuation of contacts in psychiatric care and re-
admission rate will be stratified by whether the patient
Fig. 1 Overview study design
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can be characterized as having severe mental disorder.
Severe mental disorder is defined as.
(A) being diagnosed with any of the following
disorders:
– F20.X-F22.X (schizophrenia),
– F25.X (schizo-effective disorders),
– F30.X (mania),
– F31.X (bipolar disorder),
– F32.2-F32.3 (severe depressive episode),
– F33.X (recurrent depressive disorder),
– F41.X (other anxiety disorders),
– F42.X (obsessive-compulsive disorder) or
– F60.31 (borderline personality) and as
(B) having any under (A) defined mental disorders di-
agnosed at least twice (two different quarters) each year
during the last 2 years.
In addition, the following cost outcome parameters will
be investigated, all secondary outcome parameters (Fig. 2):
– direct inpatient psychiatric health care costs,
– direct overall psychiatric health care costs,
– costs of outpatient care / medicines and
transparency of health care services.
Costs as direct care costs within a period of 12 months
after study inclusion are measured with SHI billing/ac-
counting data, considering a differentiation of psychi-
atric vs. non-psychiatric care costs and health care
sector where costs emerge.
Black arrows within the boxes in Fig. 2 symbolize the
expected model effects, e.g. it is expected that the fre-
quency and duration of inpatient care will decrease while
the frequency and intensity of outpatient care will in-
crease. Grey arrows between the boxes in Fig. 2 indicate
the interdependencies between the outcome parameters.
All outcome parameters will be estimated for patients
in model hospitals and compared to those of patients in
control hospitals.
Data
Information on 18 model projects will be evaluated. While
the first included model projects started in January 2013,
the latest model projects started in January 2017. Analyses
will be based on health claims data provided by participat-
ing SHI funds. A common data set description was de-
fined to determine the content and format of data
extracted by the SHI funds. Data of inpatient and out-
patient care including psychiatric outpatients department
(PIA, for patients in need of particularly intensive and
complex near-hospital care due to the nature, severity or
duration of their mental disorder), of pharmaceutical and
non-pharmaceutical treatments and of sick leave from 89
SHI funds will be analyzed. Once every year, all participat-
ing SHI funds send anonymized data on patients who ful-
fil inclusion criteria to the University of Magdeburg (data
management unit of the study). The data transfer is based
on a consensus of a data record description, which allows
a homogenization of the 89 SHI funds data. The data
management unit synthesizes, checks and merges the in-
formation from the different SHI funds and sends it to the
TU Dresden and the WIG2 Leipzig for data analysis.
While the TU Dresden evaluates model effectiveness,
WIG2 analyzes cost information. Following this, TU Dres-
den and WIG2 jointly evaluate cost-effectiveness of
models vs. routine care using cost-effectiveness analyses.
Fig. 2 Outcome parameters and hypothesized effects, primary outcome parameters in bold printing
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Statistical analysis
All outcome parameters will be analyzed for the first year,
the third year and the first 5 years (total evaluated model
time) after the onset of the model project. The analysis for
first or third year includes all patients that were initially
treated in the model or control hospital during the first or
third year of the contracts of the model hospital, respect-
ively. The total evaluated model time includes all patients
with initial treatment within the evaluation period, i.e. first
48 months after model start. Outcome parameters will be
compared with the patient-individual pre-time (up to 2
years before study entrance). An a priori power analyses for
the primary outcome parameters using α = 0.025 and 1 –
β = 0.80 revealed that effects for even small hospitals could
be verified with the estimated dataset.
Generalized multi-level models will be estimated con-
trolling for dependencies within multiple observations
within subjects. Furthermore, additional confounding re-
gressors will be added. Regressors are mental disorders,
severe mental disorders, age, sex, co-morbidities, care
level, number of sick leave days before study inclusion,
study inclusion through hospital or PIA. Covariance
structures between these regressors will also be analyzed
beforehand to identify potential multicollinearity [40].
Effects and costs will be analyzed from a SHI perspec-
tive. Primary (confirmatory) analyses will be performed
according to the intention-to-treat approach. In the
intention-to-treat approach, all patients will be evaluated
as they will always be treated in the model or control
hospital in which they were initially treated after start of
the model project. Later changes in treatment hospitals
will be disregarded.
In addition, the per-protocol approach is used to
investigate the influence of drop-outs on the study
results. In the per-protocol analysis, the following
patients will be excluded from the analysis. Patients
 with at least two inpatient nights in a psychiatric
hospital other than their allocated model or control
hospital or
 with at least two visits in PIA of a psychiatric
hospital other than their allocated model or control
hospital or
 who were preponderantly treated in a psychiatric
hospital other than their allocated model or control
hospital.
A significance level of p ≤ 0.05 will be set for all
analyses.
For the cost-effectiveness analysis, primary outcome pa-
rameters and costs will be compared between model and
control hospitals using incremental cost-effectiveness ratio
(ICER) as costs per one-day-of-hospital-stay avoided and as
costs per one-day-of-sick-leave avoided. Cost-effectiveness
planes will be used to visualize the bootstrapped replicates
for the ICER [41, 42].
Ethics and data protection
As exclusively anonymous data will be obtained from the
statutory health insurance funds, the ethical committee of
the University of Magdeburg confirmed that no ethical
approval is necessary. Data are handled, analyzed and
reported according to Good Epidemiological Practice
(GEP) [43], Good Practice of Secondary Data Analysis
(GPS) [26], a Consensus German Reporting Standard for
Secondary Data Analyses, Version 2 (STROSA 2) [27] and
German Recommendations on Health Economic Evalu-
ation (Hanover Consensus) [44].
Discussion
The evaluation of complex interventions in the health care
sector is one main task of health service research and is the
basis for evidence-based health care provision and develop-
ment. Evaluations should investigate appropriate, structur-
ally comparable control groups to avoid bias [45, 46]. One
cornerstone of the described evaluation is the transparent
and objective identification of appropriate control hospitals.
As such an algorithm was not available before the start of
this evaluation, the definition of this algorithm was one of
the first steps of this evaluation. The algorithm has been
shown to be practicable and expedient to identify appropri-
ate control clinics for a priori defined model clinics based
on administrative, especially claims data [32].
The merging and analysis of data from different statu-
tory health insurance funds and the evaluation of complex
interventions compared to routine care pose a huge tech-
nical and methodological challenge. Until today, there is
no database in Germany encompassing all claims data of
all SHI funds included in this study. This is why no other
study in Germany has yet evaluated health claims data
from so many different SHI funds. Prior experience about
data handling and analysis is sparse. The experiences and
findings from this study will generate methodological
insight for further joint evaluations across different health
insurance companies. Administrative data, especially
claims data, offer opportunities to prospectively and retro-
spectively analyze detailed information where primary
data are not available, impossible to retrieve or limited
due to recall, information or further bias. While routine
data offer essential information, preference-based and
patient-centered information cannot be obtained. How-
ever, the presented methods are the best choice for use of
administrative data to evaluate complex interventions.
The project EVA64 evaluates complex interventions
regarding effectiveness, costs and efficiency of each
model project separately as well as jointly to optimize
the health care of patients with mental disorders in
Germany. The evaluation on the basis of data from
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almost all German statutory health insurance funds allows
a comprehensive evaluation of the health care of mental
disorders. Such a common evaluation is unique in
Germany and is, as indicated above, requested from other
studies. A huge array of data including inpatient, out-
patient, medication and sick leave will be used. In
addition, the long-term evaluation allows for more stable
evaluation and analysis. The described development of an
objective selection of control hospitals can be used beyond
this study. So far, no other study in Germany has analyzed
such a large number of SHI funds. No other German pro-
ject has brought together so many SHI funds for one com-
mon aim. No other evaluation project has yet evaluated so
many model projects with one common study design and
one database. Politics and SHI funds together have en-
abled researchers to form the basis of an evidence-guided
decision on psychiatric care for adults and children/ado-
lescents in Germany.
Information derived from this evaluation will give
further insight into effectivity, cost and cost-effectivity
of 18 model projects based on capitation principle.
As requested by prior research, this project evaluates
information about model projects on a common
scientific basis [3, 24].
The indirect aim of the model projects is to evolve a
system where the treatment can be adjusted flexibly to
the patient and not the patient to the treatment. If the
model projects in psychiatric care will be estimated to
be efficient and cost-effective compared to routine care,
this evaluation will provide arguments for a new struc-
turing of routine care for patients with mental disorders
in Germany.
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